BioMarin Pharmaceutical Inc 2025 Sustainability Report
Company: BioMarin Pharmaceutical Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: Sustainability Report
Pages: 34
The report is BioMarin's first Corporate Responsibility Report and describes a completed limited materiality assessment plus a double materiality assessment aligned with CSRD. It highlights the transition of the Corporate Responsibility Committee into a cross-functional ESG team, with executive steering and Board committee oversight. Environmental initiatives include renewable electricity purchasing, site solar generation, laboratory plastics diversion and energy-efficiency projects.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.